Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Marco, Valgimigli"'
Autor:
Luigi Biasco, Amabile Valotta, Catherine Klersy, Marco Valgimigli, Luca Gabutti, Roberto Della Bruna, Alberto Pagnamenta, Lorenzo Ruinelli, Gaetano Senatore, Giovanni B. Pedrazzini
Publikováno v:
International Journal of Cardiology. 369:48-53
Myocardial injury (MINJ) is a well-recognized prognostic marker in different acute cardio-respiratory illnesses, nonetheless, its relevance in Influenza remains poorly defined. Our aim was to assess incidence, correlates, short and mid-term prognosti
Autor:
Juan F, Iglesias, Marco, Valgimigli, Federico, Carbone, Nathalie, Lauriers, Pier-Giorgio, Masci, Sophie, Degrauwe
Publikováno v:
Cardiology Journal. 29:591-600
Morphine reduces absorption and delays action onset of potent oral P2Y₁₂ receptor inhibitors in patients with ST-segment elevation myocardial infarction (STEMI). We sought to determine the differential effects of fentanyl compared to morphine on
Autor:
Alessandro Spirito, Angelo Quagliana, Marco Coiro, Gebremedhin Melaku Melaku, Stijn Vandenberghe, Gregor Leibundgut, Jonas Häner, Marco Moccetti, Marco Araco, Hector Garcia-Garcia Garcia-Garcia, Marco Valgimigli
Publikováno v:
EuroIntervention
BACKGROUND: There is no established technique for managing large thrombus burden (LTB) in patients with acute coronary syndrome (ACS). AIMS: The aim of this study was to assess the safety and efficacy of the NeVa (Vesalio) mechanical thrombectomy dev
Autor:
Yasushi Ueki, Thomas Zanchin, Sylvain Losdat, Alexios Karagiannis, Tatsuhiko Otsuka, George C. M. Siontis, Jonas Häner, Stefan Stortecky, Thomas Pilgrim, Marco Valgimigli, Stephan Windecker, Lorenz Räber
Publikováno v:
PLoS ONE, Vol 17, Iss 2 (2022)
Ueki, Yasushi; Zanchin, Thomas; Losdat, Sylvain; Karagiannis, Alexios; Otsuka, Tatsuhiko; Siontis, George C M; Häner, Jonas; Stortecky, Stefan; Pilgrim, Thomas; Valgimigli, Marco; Windecker, Stephan; Räber, Lorenz (2022). Self-reported non-adherence to P2Y12 inhibitors in patients undergoing percutaneous coronary intervention: Application of the medication non-adherence academic research consortium classification. PLoS ONE, 17(2), e0263180. Public Library of Science 10.1371/journal.pone.0263180
Ueki, Yasushi; Zanchin, Thomas; Losdat, Sylvain; Karagiannis, Alexios; Otsuka, Tatsuhiko; Siontis, George C M; Häner, Jonas; Stortecky, Stefan; Pilgrim, Thomas; Valgimigli, Marco; Windecker, Stephan; Räber, Lorenz (2022). Self-reported non-adherence to P2Y12 inhibitors in patients undergoing percutaneous coronary intervention: Application of the medication non-adherence academic research consortium classification. PLoS ONE, 17(2), e0263180. Public Library of Science 10.1371/journal.pone.0263180
Aims The Non-adherence Academic Research Consortium (NARC) has recently developed a consensus-based standardized classification for medication non-adherence in cardiovascular clinical trials. We aimed to assess the prevalence of NARC-defined self-rep
Autor:
Luc Janssens, Hans Peter Stoll, Pascal Vranckx, Marco Valgimigli, Antonio Colombo, Hidenori Komiyama, Peter Jüni, Ply Chichareon, Stephan Windecker, Philippe Gabriel Steg, Chun Chin Chang, Kenneth De Wilder, Norihiro Kogame, Yves Louvard, Alaide Chieffo, Mariusz Tomaniak, Yoshinobu Onuma, Scot Garg, Kuniaki Takahashi, Christian W. Hamm, Rodrigo Modolo, Patrick W. Serruys
Publikováno v:
Catheterization and cardiovascular interventions, 96(1), 100-111. Wiley-Liss Inc.
Catheterization and Cardiovascular Interventions, 96(1), 100-111. Wiley-Liss Inc.
Catheterization and Cardiovascular Interventions, 96(1), 100-111. Wiley-Liss Inc.
Background The aim of this study was to investigate the impact of ticagrelor monotherapy following 1-month dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) for bifurcation lesions. Methods GLOBAL LEADERS was a randomize
Autor:
Norihiro Kogame, Krzysztof J. Filipiak, Mariusz Tomaniak, Franz-Josef Neumann, Osama Ibrahim Ibrahim Soliman, Valeri Gelev, Ply Chichareon, Robert-Jan van Geuns, Jan G.P. Tijssen, Philippe Brunel, Zoltan Jambrik, Yoshinobu Onuma, Global Leaders Study Investigators, Jean-François Morelle, Rodrigo Modolo, Chun Chin Chang, Patrick W. Serruys, Mariana Konteva, Tessa Rademaker-Havinga, Marco Valgimigli, Sylvain Plante, Philippe Gabriel Steg, Stephan Windecker, Ernest Spitzer, Kuniaki Takahashi, Farzin Beygui, Rosana Hernandez Antolin, Robert F. Storey, Christian W. Hamm
Publikováno v:
European Heart Journal-Cardiovascular Pharmacotherapy, 6, 222-230
European Heart Journal. Cardiovascular pharmacotherapy, 6(4), 222-230. Oxford University Press
Tomaniak, Mariusz; Chichareon, Ply; Takahashi, Kuniaki; Kogame, Norihiro; Modolo, Rodrigo; Chang, Chun Chin; Spitzer, Ernest; Neumann, Franz-Josef; Plante, Sylvain; Hernández Antolin, Rosana; Jambrik, Zoltan; Gelev, Valeri; Brunel, Philippe; Konteva, Mariana; Beygui, Farzin; Morelle, Jean-Francois; Filipiak, Krzysztof J; van Geuns, Robert-Jan; Soliman, Osama; Tijssen, Jan; ... (2020). Impact of chronic obstructive pulmonary disease and dyspnoea on clinical outcomes in ticagrelor treated patients undergoing percutaneous coronary intervention in the randomized GLOBAL LEADERS trial. European heart journal. Cardiovascular pharmacotherapy, 6(4), pp. 222-230. Oxford University Press 10.1093/ehjcvp/pvz052
European heart journal. Cardiovascular pharmacotherapy, 6(4), 222-230. Oxford University Press
European Heart Journal-Cardiovascular Pharmacotherapy, 6, 4, pp. 222-230
European Heart Journal. Cardiovascular pharmacotherapy, 6(4), 222-230. Oxford University Press
Tomaniak, Mariusz; Chichareon, Ply; Takahashi, Kuniaki; Kogame, Norihiro; Modolo, Rodrigo; Chang, Chun Chin; Spitzer, Ernest; Neumann, Franz-Josef; Plante, Sylvain; Hernández Antolin, Rosana; Jambrik, Zoltan; Gelev, Valeri; Brunel, Philippe; Konteva, Mariana; Beygui, Farzin; Morelle, Jean-Francois; Filipiak, Krzysztof J; van Geuns, Robert-Jan; Soliman, Osama; Tijssen, Jan; ... (2020). Impact of chronic obstructive pulmonary disease and dyspnoea on clinical outcomes in ticagrelor treated patients undergoing percutaneous coronary intervention in the randomized GLOBAL LEADERS trial. European heart journal. Cardiovascular pharmacotherapy, 6(4), pp. 222-230. Oxford University Press 10.1093/ehjcvp/pvz052
European heart journal. Cardiovascular pharmacotherapy, 6(4), 222-230. Oxford University Press
European Heart Journal-Cardiovascular Pharmacotherapy, 6, 4, pp. 222-230
Aims To evaluate long-term safety and efficacy of ticagrelor monotherapy in patients undergoing percutaneous coronary interventions (PCIs) in relation to chronic obstructive pulmonary disease (COPD) at baseline and the occurrence of dyspnoea reported
Autor:
Pascal Vranckx, Joanna J. Wykrzykowska, Rutao Wang, Stephan Windecker, Hideyuki Kawashima, Manuel de Sousa Almeida, Pierre Lantelme, Philippe Gabriel Steg, Patrick W. Serruys, Robbert J. de Winter, Kuniaki Takahashi, Nikos Werner, Pascal Barraud, Christian W. Hamm, Yoshinobu Onuma, Peter Barlis, Chao Gao, Mariusz Tomaniak, Hironori Hara, Marco Valgimigli, Masafumi Ono, Emmanuel Teiger, Scot Garg
Publikováno v:
International journal of cardiology, 320, 27-34. Elsevier Ireland Ltd
International Journal of Cardiology, 320, 27-34. Elsevier Ireland Ltd
International Journal of Cardiology, 320, 27-34. Elsevier Ireland Ltd
Backgrounds: Data on optimal antiplatelet therapy in patients undergoing stenting of the proximal left anterior descending artery (LAD) are limited. Methods: This is a post-hoc analysis of the GLOBAL LEADERS trial, a prospective, multi-center, random
Autor:
Nuccia Morici, Stefano Savonitto, Gabriele Crimi, Stefano De Servi, Claudio Montalto, Marco Valgimigli, Tullio Palmerini
Publikováno v:
Thrombosis and Haemostasis. 121:1255-1257
Autor:
Claudio Galletti, Claudio Vicini, Filippo Montevecchi, Giovanni Cammaroto, Francesco Costa, Marco Valgimigli, Giuseppe Andò, Maria Victoria Garcia Ruiz, Francesco Galletti
Publikováno v:
Cammaroto, Giovanni; Costa, Francesco; Ruiz, Maria Victoria Garcia; Andò, Giuseppe; Vicini, Claudio; Montevecchi, Filippo; Galletti, Claudio; Galletti, Francesco; Valgimigli, Marco (2019). Obstructive sleep apnoea syndrome and endothelial function: potential impact of different treatment strategies-meta-analysis of prospective studies. European archives of oto-rhino-laryngology, 276(8), pp. 2331-2338. Springer 10.1007/s00405-019-05486-6
PURPOSE Previous studies have shown an association between obstructive sleep apnoea syndrome (OSAS) and cardiovascular events. Whether this association is mediated by an impairment of endothelial function, which is itself a driver of elevated cardiov
Autor:
Pascal Vranckx, Yoshinobu Onuma, Olivier F. Bertrand, Tian Hai Koh, Robert-Jan van Geuns, Rodrigo Modolo, Osama Ibrahim Ibrahim Soliman, Rui Cruz Ferreira, Chun Chin Chang, Aris Moschovitis, Marco Valgimigli, Sing-Chien Yap, Stephen P. Hoole, Hidenori Komiyama, Christian W. Hamm, Amanda G. M. R. Sousa, Azfar Zaman, Philippe Gabriel Steg, Patrick W. Serruys, Tommaso Gori, Peter Jüni, Ernest Spitzer, Kuniaki Takahashi, Bernhard Frey, Stephan Windecker, Mariusz Tomaniak, Ply Chichareon, Norihiro Kogame
Publikováno v:
American journal of cardiology, 124(12), 1833-1840. Elsevier Inc.
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
American Journal of Cardiology, 124(12), 1833-1840. Elsevier Inc.
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
American Journal of Cardiology, 124(12), 1833-1840. Elsevier Inc.
Q-wave myocardial infarction (QWMI) comprises 2 entities. First, a clinically evident MI, which can occur spontaneously or be related to a coronary procedure. Second, silent MI which is incidentally detected on serial electrocardiographic (ECG) asses